In veterinary medicine, thrombo-embolism (TE) is an under-appreciated medical condition that requires immediate recognition. Since TE is multifactorial and its mode of presentation may vary, veterinarians face great difficulties in making a definitive diagnosis in a timely manner. In addition, most of the underlying conditions that give rise to TE are life-threatening and an aggressive diagnostic and therapeutic approach is required. Not only does the diagnosis and treatment of this condition require the collaboration of many specialties, the costs of therapy can be excessive with a high risk of recurrence. As such, owners have to be thoroughly informed before the therapy commences. While TE has been well-characterized in humans and is associated with significant morbidity and mortality, little information of similar quality is available in veterinary medicine. In addition, TE in animals is distinct from its human counterpart and we cannot simply adapt what is known from human clinical trials. With the promise of improvements in imaging modalities that improve our diagnostic capabilities, the window of opportunity to treat TE increases. This article focuses on aetiology, clinical presentation, diagnosis, and treatment of dogs and cats affected by TE.
Prothrombotic conditions, non-pulsatile blood flow, endothelial damage, hypercoagulability, clinical presentationThrombo-embolism (TE) in animal patients (canine and feline) can occur at various anatomical locations, including pulmonary vessels, portal vein, vena cava, aortic trifurcation, heart, renal and cerebral arteries, intestinal and mesenteric vessels, spleen, iliac, femoral, coronary and brachial arteries, femoral vein, and vessels of the microcirculation (Butler 1971;Liu et al. 1986; Klein et al. 1989;LaRue and Murtaugh 1990;Laste et al. 1992;Van Winkle and Bruce 1993;Rawlings et al. 1993;Sottiaux and Franck 1998;Palmer et al. 1998;Driehuys et al. 1998;Sottiaux and Franck 1999; Diaz Espineira 1999;Bateman et al. 1999;Norris et al. 1999;Boswood et al. 2000; Tsujino et al. 2005; Gonçalves et al. 2008). The clinical effects of thrombo-embolism depend mainly on the size and site of the final destination of the thrombus/embolus.It is commonly accepted that arterial thrombi are composed predominantly of platelets as compared to fibrin. This is in contrast to vein thrombi, where platelets are scarce and there are larger amounts of cross-linked fibrin. Arterial clots are also generally firmly attached to the underlying vessel wall. In this setting, clot dislodgement will sometimes occur, causing re-canalization of the vessel with relief of the obstruction, but the threat of embolism distally remains. In contrast, venous thrombi are mainly associated with lower limb deep vein thrombosis (DVT) in humans. DVT, however, is not common in veterinary patients. This is thought to be due to the differences in the epigenetics, platelet structure, vascular anatomy and physiological non-bipedal circulation. In fact, venous thrombi tend to be occlusive with resulting ...